MMP2 and neoplasm: By introducing a peptide clamp with a MMP-2/-9 cleavable linker that imposes steric hindrance on antigen binding, the inhibition is subsequently reversed through proteolytic cleavage of the linker, thereby enabling selective restoration of antigen recognition predominantly within the tumor microenvironment (TME).